| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | mRNA binding | 5.17e-07 | 694 | 16 | 7 | GO:0003729 | |
| GeneOntologyMolecularFunction | lamin binding | 1.02e-04 | 19 | 16 | 2 | GO:0005521 | |
| GeneOntologyMolecularFunction | sequence-specific mRNA binding | 1.02e-04 | 19 | 16 | 2 | GO:1990825 | |
| GeneOntologyMolecularFunction | ribonucleoprotein complex binding | 5.49e-04 | 206 | 16 | 3 | GO:0043021 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 1.18e-03 | 64 | 16 | 2 | GO:0036002 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 1.28e-03 | 276 | 16 | 3 | GO:0003730 | |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 3.49e-03 | 111 | 16 | 2 | GO:0003727 | |
| GeneOntologyMolecularFunction | ribosome binding | 4.07e-03 | 120 | 16 | 2 | GO:0043022 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 5.04e-03 | 134 | 16 | 2 | GO:0003697 | |
| GeneOntologyBiologicalProcess | RNA splicing | RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 4.69e-13 | 502 | 16 | 10 | GO:0008380 |
| GeneOntologyBiologicalProcess | mRNA processing | 6.29e-11 | 551 | 16 | 9 | GO:0006397 | |
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 8.69e-11 | 358 | 16 | 8 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 8.69e-11 | 358 | 16 | 8 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 9.49e-11 | 362 | 16 | 8 | GO:0000375 | |
| GeneOntologyBiologicalProcess | regulation of RNA splicing | 9.82e-11 | 207 | 16 | 7 | GO:0043484 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | FXR2 RBM3 AKAP8L HNRNPH1 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 1.80e-10 | 917 | 16 | 10 | GO:0016071 |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 4.71e-10 | 443 | 16 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | regulation of mRNA processing | 1.38e-09 | 158 | 16 | 6 | GO:0050684 | |
| GeneOntologyBiologicalProcess | RNA processing | RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 2.14e-08 | 1500 | 16 | 10 | GO:0006396 |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 3.66e-08 | 129 | 16 | 5 | GO:0048024 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.17e-06 | 259 | 16 | 5 | GO:1903313 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.24e-06 | 28 | 16 | 3 | GO:0048025 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.38e-06 | 29 | 16 | 3 | GO:0050686 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.58e-06 | 115 | 16 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.06e-06 | 33 | 16 | 3 | GO:0033119 | |
| GeneOntologyBiologicalProcess | positive regulation of translation | 4.69e-06 | 151 | 16 | 4 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of RNA splicing | 1.48e-05 | 63 | 16 | 3 | GO:0033120 | |
| GeneOntologyBiologicalProcess | regulation of RNA export from nucleus | 7.62e-05 | 17 | 16 | 2 | GO:0046831 | |
| GeneOntologyBiologicalProcess | regulation of nucleobase-containing compound transport | 1.06e-04 | 20 | 16 | 2 | GO:0032239 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.78e-04 | 145 | 16 | 3 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 3.10e-04 | 175 | 16 | 3 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 3.10e-04 | 175 | 16 | 3 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 3.26e-04 | 178 | 16 | 3 | GO:0051236 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 3.88e-04 | 189 | 16 | 3 | GO:0030216 | |
| GeneOntologyBiologicalProcess | regulation of translation | 4.71e-04 | 494 | 16 | 4 | GO:0006417 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 5.00e-04 | 206 | 16 | 3 | GO:0061157 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression | 5.10e-04 | 1446 | 16 | 6 | GO:0010628 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA splicing, via spliceosome | 5.24e-04 | 44 | 16 | 2 | GO:0048026 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 5.36e-04 | 211 | 16 | 3 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 5.36e-04 | 211 | 16 | 3 | GO:0061014 | |
| GeneOntologyBiologicalProcess | RNA localization | 5.81e-04 | 217 | 16 | 3 | GO:0006403 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA processing | 6.49e-04 | 49 | 16 | 2 | GO:0050685 | |
| GeneOntologyBiologicalProcess | synapse maturation | 6.76e-04 | 50 | 16 | 2 | GO:0060074 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 8.67e-04 | 249 | 16 | 3 | GO:0015931 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.27e-03 | 284 | 16 | 3 | GO:0009913 | |
| GeneOntologyBiologicalProcess | positive regulation of dendritic spine development | 1.32e-03 | 70 | 16 | 2 | GO:0060999 | |
| GeneOntologyBiologicalProcess | regulation of epidermis development | 1.36e-03 | 71 | 16 | 2 | GO:0045682 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 1.37e-03 | 292 | 16 | 3 | GO:0043488 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | 1.41e-03 | 1153 | 16 | 5 | GO:0010608 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.51e-03 | 75 | 16 | 2 | GO:0045109 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.60e-03 | 308 | 16 | 3 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 1.61e-03 | 309 | 16 | 3 | GO:0061013 | |
| GeneOntologyBiologicalProcess | alternative mRNA splicing, via spliceosome | 1.68e-03 | 79 | 16 | 2 | GO:0000380 | |
| GeneOntologyBiologicalProcess | response to insulin | 2.16e-03 | 342 | 16 | 3 | GO:0032868 | |
| GeneOntologyBiologicalProcess | regulation of dendritic spine development | 2.22e-03 | 91 | 16 | 2 | GO:0060998 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 2.47e-03 | 96 | 16 | 2 | GO:0006405 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 2.62e-03 | 99 | 16 | 2 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 2.67e-03 | 100 | 16 | 2 | GO:0045103 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 2.76e-03 | 373 | 16 | 3 | GO:0006402 | |
| GeneOntologyBiologicalProcess | skin development | 2.76e-03 | 373 | 16 | 3 | GO:0043588 | |
| GeneOntologyBiologicalProcess | translation | 3.13e-03 | 824 | 16 | 4 | GO:0006412 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 4.17e-03 | 432 | 16 | 3 | GO:0006401 | |
| GeneOntologyBiologicalProcess | epidermis development | 5.00e-03 | 461 | 16 | 3 | GO:0008544 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 5.09e-03 | 464 | 16 | 3 | GO:0141188 | |
| GeneOntologyBiologicalProcess | dendritic spine development | 5.23e-03 | 141 | 16 | 2 | GO:0060996 | |
| GeneOntologyBiologicalProcess | regulation of nucleocytoplasmic transport | 5.30e-03 | 142 | 16 | 2 | GO:0046822 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 7.36e-03 | 530 | 16 | 3 | GO:0043434 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 7.94e-03 | 175 | 16 | 2 | GO:0031644 | |
| GeneOntologyCellularComponent | ribonucleoprotein complex | RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 2.08e-09 | 1194 | 16 | 10 | GO:1990904 |
| GeneOntologyCellularComponent | spliceosomal complex | 4.38e-07 | 215 | 16 | 5 | GO:0005681 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 5.19e-05 | 97 | 16 | 3 | GO:0071013 | |
| GeneOntologyCellularComponent | nuclear speck | 2.66e-04 | 431 | 16 | 4 | GO:0016607 | |
| GeneOntologyCellularComponent | dendrite | 3.45e-04 | 858 | 16 | 5 | GO:0030425 | |
| GeneOntologyCellularComponent | dendritic tree | 3.48e-04 | 860 | 16 | 5 | GO:0097447 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.64e-04 | 1377 | 16 | 6 | GO:0140513 | |
| GeneOntologyCellularComponent | nuclear body | 4.36e-04 | 903 | 16 | 5 | GO:0016604 | |
| GeneOntologyCellularComponent | intermediate filament | 6.37e-04 | 227 | 16 | 3 | GO:0005882 | |
| GeneOntologyCellularComponent | postsynapse | 7.55e-04 | 1018 | 16 | 5 | GO:0098794 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 9.77e-04 | 263 | 16 | 3 | GO:0045111 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.04e-03 | 269 | 16 | 3 | GO:0036464 | |
| GeneOntologyCellularComponent | cornified envelope | 1.25e-03 | 69 | 16 | 2 | GO:0001533 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 1.26e-03 | 287 | 16 | 3 | GO:0035770 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 1.76e-03 | 1228 | 16 | 5 | GO:0036477 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.40e-03 | 96 | 16 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | keratin filament | 2.45e-03 | 97 | 16 | 2 | GO:0045095 | |
| GeneOntologyCellularComponent | postsynaptic density | 4.53e-03 | 451 | 16 | 3 | GO:0014069 | |
| GeneOntologyCellularComponent | asymmetric synapse | 5.30e-03 | 477 | 16 | 3 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 6.14e-03 | 503 | 16 | 3 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 6.84e-03 | 523 | 16 | 3 | GO:0098984 | |
| GeneOntologyCellularComponent | axon terminus | 1.10e-02 | 210 | 16 | 2 | GO:0043679 | |
| GeneOntologyCellularComponent | neuron projection terminus | 1.34e-02 | 233 | 16 | 2 | GO:0044306 | |
| GeneOntologyCellularComponent | dendritic spine | 1.44e-02 | 242 | 16 | 2 | GO:0043197 | |
| GeneOntologyCellularComponent | neuron spine | 1.50e-02 | 247 | 16 | 2 | GO:0044309 | |
| GeneOntologyCellularComponent | ribosome | 1.73e-02 | 267 | 16 | 2 | GO:0005840 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.28e-02 | 817 | 16 | 3 | GO:0098978 | |
| MousePheno | abnormal coat/ hair morphology | 1.00e-04 | 854 | 14 | 6 | MP:0000367 | |
| Domain | RRM_1 | 2.02e-10 | 208 | 16 | 7 | PF00076 | |
| Domain | RRM | 2.72e-10 | 217 | 16 | 7 | SM00360 | |
| Domain | RRM_dom | 3.72e-10 | 227 | 16 | 7 | IPR000504 | |
| Domain | RRM | 4.08e-10 | 230 | 16 | 7 | PS50102 | |
| Domain | - | 6.17e-10 | 244 | 16 | 7 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 9.10e-10 | 258 | 16 | 7 | IPR012677 | |
| Domain | zf-RNPHF | 2.06e-06 | 3 | 16 | 2 | PF08080 | |
| Domain | Znf_CHHC | 2.06e-06 | 3 | 16 | 2 | IPR012996 | |
| Domain | KH_1 | 4.75e-04 | 38 | 16 | 2 | PF00013 | |
| Domain | - | 5.01e-04 | 39 | 16 | 2 | 3.30.1370.10 | |
| Domain | KH_dom | 5.27e-04 | 40 | 16 | 2 | IPR004087 | |
| Domain | KH | 5.27e-04 | 40 | 16 | 2 | SM00322 | |
| Domain | KH_TYPE_1 | 5.81e-04 | 42 | 16 | 2 | PS50084 | |
| Domain | KH_dom_type_1 | 6.37e-04 | 44 | 16 | 2 | IPR004088 | |
| Domain | Keratin_I | 6.37e-04 | 44 | 16 | 2 | IPR002957 | |
| Domain | Intermediate_filament_CS | 1.30e-03 | 63 | 16 | 2 | IPR018039 | |
| Domain | Filament | 1.65e-03 | 71 | 16 | 2 | SM01391 | |
| Domain | Prefoldin | 1.70e-03 | 72 | 16 | 2 | IPR009053 | |
| Domain | IF | 1.70e-03 | 72 | 16 | 2 | PS00226 | |
| Domain | Filament | 1.75e-03 | 73 | 16 | 2 | PF00038 | |
| Domain | IF | 1.89e-03 | 76 | 16 | 2 | IPR001664 | |
| Pathway | WP_MRNA_PROCESSING | FXR2 BCLAF1 RBM3 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 1.21e-13 | 451 | 16 | 11 | MM15946 |
| Pathway | WP_MRNA_PROCESSING | 4.12e-11 | 126 | 16 | 7 | M39406 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.61e-09 | 212 | 16 | 7 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.20e-08 | 283 | 16 | 7 | M13087 | |
| Pathway | REACTOME_MRNA_SPLICING | 2.16e-06 | 201 | 16 | 5 | MM15411 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 6.97e-06 | 724 | 16 | 7 | M16843 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.03e-05 | 277 | 16 | 5 | MM15414 | |
| Pathway | KEGG_SPLICEOSOME | 3.67e-04 | 127 | 16 | 3 | M2044 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 4.45e-04 | 612 | 16 | 5 | MM15547 | |
| Pathway | REACTOME_KERATINIZATION | 6.33e-04 | 153 | 16 | 3 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 1.74e-03 | 217 | 16 | 3 | M27640 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.56e-03 | 67 | 16 | 2 | M27694 | |
| Pathway | WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME | 3.03e-03 | 73 | 16 | 2 | M39401 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.99e-03 | 84 | 16 | 2 | M725 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.27e-03 | 87 | 16 | 2 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 9.17e-03 | 129 | 16 | 2 | M27649 | |
| Pubmed | FXR2 RBM3 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 6.52e-17 | 347 | 16 | 10 | 16033648 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | KRT17 FXR2 BCLAF1 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR | 5.64e-16 | 430 | 16 | 10 | 38172120 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | KRT17 FXR2 BCLAF1 RBM3 KRT10 HNRNPH1 HNRNPH2 DHX9 HNRNPR SRSF4 SRSF6 | 5.70e-16 | 678 | 16 | 11 | 30209976 |
| Pubmed | 6.27e-16 | 138 | 16 | 8 | 30320910 | ||
| Pubmed | FXR2 BCLAF1 RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 9.91e-16 | 713 | 16 | 11 | 29802200 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | FXR2 BCLAF1 AKAP8L HNRNPH1 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 1.92e-15 | 486 | 16 | 10 | 30940648 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | FXR2 BCLAF1 RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 3.86e-15 | 807 | 16 | 11 | 22681889 |
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 6.34e-15 | 89 | 16 | 7 | 22446626 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | KRT17 FXR2 BCLAF1 AKAP8L KRT10 HNRNPH1 HNRNPK DHX9 HNRNPR SRSF6 | 1.72e-14 | 605 | 16 | 10 | 28977666 |
| Pubmed | 2.73e-14 | 109 | 16 | 7 | 12226669 | ||
| Pubmed | 5.44e-14 | 421 | 16 | 9 | 34650049 | ||
| Pubmed | 6.41e-14 | 244 | 16 | 8 | 29884807 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | FXR2 BCLAF1 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 8.95e-14 | 714 | 16 | 10 | 28302793 |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.01e-13 | 258 | 16 | 8 | 37794589 | |
| Pubmed | FXR2 BCLAF1 RBM3 AKAP8L HNRNPH1 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 1.13e-13 | 731 | 16 | 10 | 29298432 | |
| Pubmed | KRT17 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 1.90e-13 | 1153 | 16 | 11 | 29845934 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 6.84e-13 | 558 | 16 | 9 | 27591049 | |
| Pubmed | 7.05e-13 | 172 | 16 | 7 | 26336360 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BCLAF1 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 5.51e-12 | 1082 | 16 | 10 | 38697112 |
| Pubmed | 6.43e-12 | 109 | 16 | 6 | 29511296 | ||
| Pubmed | 6.93e-12 | 723 | 16 | 9 | 34133714 | ||
| Pubmed | 7.11e-12 | 725 | 16 | 9 | 27025967 | ||
| Pubmed | 9.83e-12 | 11 | 16 | 4 | 21900255 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | KRT17 FXR2 BCLAF1 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF6 | 2.41e-11 | 1257 | 16 | 10 | 36526897 |
| Pubmed | 2.54e-11 | 286 | 16 | 7 | 32041737 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | FXR2 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 3.84e-11 | 1318 | 16 | 10 | 30463901 |
| Pubmed | 6.91e-11 | 330 | 16 | 7 | 32529326 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT17 FXR2 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF6 | 7.71e-11 | 1415 | 16 | 10 | 28515276 |
| Pubmed | ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection. | 7.84e-11 | 336 | 16 | 7 | 31253590 | |
| Pubmed | The cellular EJC interactome reveals higher-order mRNP structure and an EJC-SR protein nexus. | 9.26e-11 | 169 | 16 | 6 | 23084401 | |
| Pubmed | 9.53e-11 | 971 | 16 | 9 | 33306668 | ||
| Pubmed | 9.62e-11 | 346 | 16 | 7 | 25324306 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 1.12e-10 | 989 | 16 | 9 | 36424410 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 1.19e-10 | 626 | 16 | 8 | 33644029 | |
| Pubmed | 1.71e-10 | 655 | 16 | 8 | 35819319 | ||
| Pubmed | 1.82e-10 | 660 | 16 | 8 | 32780723 | ||
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 2.34e-10 | 197 | 16 | 6 | 22365833 | |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | 3.02e-10 | 704 | 16 | 8 | 32994395 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.19e-10 | 411 | 16 | 7 | 35182466 | |
| Pubmed | 3.27e-10 | 711 | 16 | 8 | 33022573 | ||
| Pubmed | 4.03e-10 | 425 | 16 | 7 | 21081503 | ||
| Pubmed | 7.48e-10 | 239 | 16 | 6 | 26641092 | ||
| Pubmed | 7.86e-10 | 241 | 16 | 6 | 23125841 | ||
| Pubmed | 8.47e-10 | 244 | 16 | 6 | 30349055 | ||
| Pubmed | 8.68e-10 | 1247 | 16 | 9 | 27684187 | ||
| Pubmed | 8.68e-10 | 245 | 16 | 6 | 35652658 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 8.98e-10 | 477 | 16 | 7 | 31300519 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.20e-09 | 1294 | 16 | 9 | 30804502 | |
| Pubmed | 1.54e-09 | 115 | 16 | 5 | 17332742 | ||
| Pubmed | 1.70e-09 | 274 | 16 | 6 | 34244482 | ||
| Pubmed | A targeted proteomic analysis of the ubiquitin-like modifier nedd8 and associated proteins. | 2.18e-09 | 38 | 16 | 4 | 18247557 | |
| Pubmed | 2.33e-09 | 289 | 16 | 6 | 37132043 | ||
| Pubmed | 2.44e-09 | 551 | 16 | 7 | 34728620 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 2.52e-09 | 922 | 16 | 8 | 27609421 | |
| Pubmed | USP11 mediates repair of DNA-protein cross-links by deubiquitinating SPRTN metalloprotease. | 2.90e-09 | 565 | 16 | 7 | 33567341 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 3.30e-09 | 954 | 16 | 8 | 36373674 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 3.60e-09 | 583 | 16 | 7 | 29844126 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 3.98e-09 | 316 | 16 | 6 | 31665637 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 5.16e-09 | 330 | 16 | 6 | 33301849 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 5.30e-09 | 147 | 16 | 5 | 28977470 | |
| Pubmed | 5.48e-09 | 148 | 16 | 5 | 35676246 | ||
| Pubmed | 5.54e-09 | 334 | 16 | 6 | 30425250 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 5.74e-09 | 1024 | 16 | 8 | 24711643 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | 7.70e-09 | 353 | 16 | 6 | 27545878 | |
| Pubmed | 7.79e-09 | 652 | 16 | 7 | 31180492 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 8.64e-09 | 162 | 16 | 5 | 31363146 | |
| Pubmed | 1.04e-08 | 168 | 16 | 5 | 39066279 | ||
| Pubmed | Regulation of alternative splicing by SRrp86 and its interacting proteins. | 1.16e-08 | 57 | 16 | 4 | 14559993 | |
| Pubmed | 1.17e-08 | 172 | 16 | 5 | 23184937 | ||
| Pubmed | 1.36e-08 | 707 | 16 | 7 | 19738201 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | 1.41e-08 | 1149 | 16 | 8 | 35446349 | |
| Pubmed | Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. | 2.28e-08 | 13 | 16 | 3 | 17765891 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.53e-08 | 774 | 16 | 7 | 15302935 | |
| Pubmed | 2.81e-08 | 205 | 16 | 5 | 28927264 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.85e-08 | 440 | 16 | 6 | 34244565 | |
| Pubmed | 2.89e-08 | 441 | 16 | 6 | 31239290 | ||
| Pubmed | Quantitative analysis of PPT1 interactome in human neuroblastoma cells. | 3.17e-08 | 210 | 16 | 5 | 26217791 | |
| Pubmed | 3.42e-08 | 809 | 16 | 7 | 32129710 | ||
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 3.81e-08 | 462 | 16 | 6 | 31138677 | |
| Pubmed | 4.27e-08 | 223 | 16 | 5 | 20020773 | ||
| Pubmed | 4.39e-08 | 79 | 16 | 4 | 14729942 | ||
| Pubmed | 4.51e-08 | 1335 | 16 | 8 | 29229926 | ||
| Pubmed | 4.57e-08 | 844 | 16 | 7 | 25963833 | ||
| Pubmed | 4.68e-08 | 847 | 16 | 7 | 35850772 | ||
| Pubmed | LINKIN, a new transmembrane protein necessary for cell adhesion. | 4.77e-08 | 480 | 16 | 6 | 25437307 | |
| Pubmed | 5.41e-08 | 17 | 16 | 3 | 12388589 | ||
| Pubmed | 6.69e-08 | 244 | 16 | 5 | 28902428 | ||
| Pubmed | 6.83e-08 | 245 | 16 | 5 | 21182205 | ||
| Pubmed | 7.07e-08 | 513 | 16 | 6 | 25798074 | ||
| Pubmed | 9.18e-08 | 260 | 16 | 5 | 36199071 | ||
| Pubmed | Disruption of the lamin A and matrin-3 interaction by myopathic LMNA mutations. | 9.67e-08 | 96 | 16 | 4 | 25948554 | |
| Pubmed | Proteomic dissection of the von Hippel-Lindau (VHL) interactome. | 1.05e-07 | 98 | 16 | 4 | 21942715 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.13e-07 | 271 | 16 | 5 | 32433965 | |
| Pubmed | Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complex. | 1.22e-07 | 22 | 16 | 3 | 18377426 | |
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 1.34e-07 | 104 | 16 | 4 | 36055981 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | 1.46e-07 | 580 | 16 | 6 | 35676659 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.49e-07 | 582 | 16 | 6 | 20467437 | |
| Pubmed | 1.50e-07 | 107 | 16 | 4 | 32989256 | ||
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 1.50e-07 | 287 | 16 | 5 | 36180891 | |
| Pubmed | 1.81e-07 | 298 | 16 | 5 | 30737378 | ||
| Interaction | CAND1 interactions | FXR2 BCLAF1 RBM3 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 1.17e-15 | 894 | 16 | 13 | int:CAND1 |
| Interaction | RC3H1 interactions | FXR2 BCLAF1 RBM3 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 3.02e-15 | 677 | 16 | 12 | int:RC3H1 |
| Interaction | RC3H2 interactions | KRT17 FXR2 BCLAF1 RBM3 KRT10 HNRNPH1 HNRNPH2 DHX9 HNRNPR SRSF4 SRSF6 | 1.81e-13 | 667 | 16 | 11 | int:RC3H2 |
| Interaction | RBMX interactions | FXR2 RBM3 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 2.52e-13 | 461 | 16 | 10 | int:RBMX |
| Interaction | MYCN interactions | KRT17 FXR2 BCLAF1 RBM3 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 2.98e-13 | 1373 | 16 | 13 | int:MYCN |
| Interaction | CMTR1 interactions | 1.97e-12 | 218 | 16 | 8 | int:CMTR1 | |
| Interaction | CUL1 interactions | RBM3 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 3.52e-12 | 876 | 16 | 11 | int:CUL1 |
| Interaction | BRD7 interactions | FXR2 BCLAF1 AKAP8L HNRNPH1 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 6.26e-12 | 637 | 16 | 10 | int:BRD7 |
| Interaction | HNRNPA1 interactions | KRT17 BCLAF1 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 8.01e-12 | 945 | 16 | 11 | int:HNRNPA1 |
| Interaction | SNRNP70 interactions | FXR2 BCLAF1 RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 1.24e-11 | 984 | 16 | 11 | int:SNRNP70 |
| Interaction | TRIM31 interactions | 1.37e-11 | 454 | 16 | 9 | int:TRIM31 | |
| Interaction | CHD3 interactions | KRT17 FXR2 BCLAF1 AKAP8L KRT10 HNRNPH1 HNRNPK DHX9 HNRNPR SRSF6 | 3.44e-11 | 757 | 16 | 10 | int:CHD3 |
| Interaction | LARP7 interactions | KRT17 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF4 SRSF6 | 4.70e-11 | 1113 | 16 | 11 | int:LARP7 |
| Interaction | FBP1 interactions | 8.33e-11 | 348 | 16 | 8 | int:FBP1 | |
| Interaction | MEPCE interactions | KRT17 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 1.19e-10 | 859 | 16 | 10 | int:MEPCE |
| Interaction | CUL2 interactions | 1.44e-10 | 591 | 16 | 9 | int:CUL2 | |
| Interaction | ZC3H18 interactions | FXR2 BCLAF1 RBM3 AKAP8L HNRNPH1 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 1.46e-10 | 877 | 16 | 10 | int:ZC3H18 |
| Interaction | MECP2 interactions | FXR2 BCLAF1 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 2.24e-10 | 1287 | 16 | 11 | int:MECP2 |
| Interaction | CHD4 interactions | KRT17 FXR2 BCLAF1 AKAP8L KRT10 HNRNPH1 HNRNPK DHX9 HNRNPR SRSF6 | 2.82e-10 | 938 | 16 | 10 | int:CHD4 |
| Interaction | MAGOH interactions | 6.32e-10 | 264 | 16 | 7 | int:MAGOH | |
| Interaction | NDN interactions | 6.74e-10 | 453 | 16 | 8 | int:NDN | |
| Interaction | RBM39 interactions | FXR2 BCLAF1 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 7.88e-10 | 1042 | 16 | 10 | int:RBM39 |
| Interaction | SF3A2 interactions | 7.99e-10 | 273 | 16 | 7 | int:SF3A2 | |
| Interaction | CUL4B interactions | 9.09e-10 | 728 | 16 | 9 | int:CUL4B | |
| Interaction | PPIE interactions | 1.00e-09 | 282 | 16 | 7 | int:PPIE | |
| Interaction | COPS5 interactions | KRT17 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF6 | 1.36e-09 | 1102 | 16 | 10 | int:COPS5 |
| Interaction | FZR1 interactions | KRT17 FXR2 RBM3 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF6 | 2.47e-09 | 1172 | 16 | 10 | int:FZR1 |
| Interaction | HNRNPK interactions | 3.66e-09 | 853 | 16 | 9 | int:HNRNPK | |
| Interaction | CYLD interactions | 4.26e-09 | 868 | 16 | 9 | int:CYLD | |
| Interaction | FAM120A interactions | 4.40e-09 | 349 | 16 | 7 | int:FAM120A | |
| Interaction | DDRGK1 interactions | FXR2 BCLAF1 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF6 | 4.58e-09 | 1249 | 16 | 10 | int:DDRGK1 |
| Interaction | ECT2 interactions | 5.16e-09 | 887 | 16 | 9 | int:ECT2 | |
| Interaction | OBSL1 interactions | 5.97e-09 | 902 | 16 | 9 | int:OBSL1 | |
| Interaction | AATF interactions | 7.37e-09 | 376 | 16 | 7 | int:AATF | |
| Interaction | HNRNPC interactions | 9.46e-09 | 634 | 16 | 8 | int:HNRNPC | |
| Interaction | TNIP2 interactions | 9.57e-09 | 952 | 16 | 9 | int:TNIP2 | |
| Interaction | MATR3 interactions | 1.22e-08 | 655 | 16 | 8 | int:MATR3 | |
| Interaction | PRMT8 interactions | 1.39e-08 | 104 | 16 | 5 | int:PRMT8 | |
| Interaction | NR2C2 interactions | FXR2 AKAP8L KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 1.41e-08 | 1403 | 16 | 10 | int:NR2C2 |
| Interaction | NUPR1 interactions | 1.69e-08 | 683 | 16 | 8 | int:NUPR1 | |
| Interaction | CEBPB interactions | KRT17 BCLAF1 AKAP8L HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF4 SRSF6 | 1.85e-08 | 1443 | 16 | 10 | int:CEBPB |
| Interaction | RNF113A interactions | 1.87e-08 | 692 | 16 | 8 | int:RNF113A | |
| Interaction | KIF23 interactions | 1.92e-08 | 1031 | 16 | 9 | int:KIF23 | |
| Interaction | EFTUD2 interactions | KRT17 FXR2 RBM3 KRT10 HNRNPH1 HNRNPH2 HNRNPK DHX9 HNRNPR SRSF6 | 1.92e-08 | 1449 | 16 | 10 | int:EFTUD2 |
| Interaction | CIT interactions | FXR2 BCLAF1 RBM3 AKAP8L HNRNPH2 HNRNPK RBMXL2 DHX9 HNRNPR SRSF6 | 1.93e-08 | 1450 | 16 | 10 | int:CIT |
| Interaction | SNRPC interactions | 2.18e-08 | 440 | 16 | 7 | int:SNRPC | |
| Interaction | KIF20A interactions | 2.28e-08 | 1052 | 16 | 9 | int:KIF20A | |
| Interaction | HNRNPA2B1 interactions | 3.65e-08 | 754 | 16 | 8 | int:HNRNPA2B1 | |
| Interaction | PHB1 interactions | 4.02e-08 | 1123 | 16 | 9 | int:PHB1 | |
| Interaction | DCUN1D1 interactions | 4.37e-08 | 275 | 16 | 6 | int:DCUN1D1 | |
| Interaction | USP14 interactions | 4.49e-08 | 489 | 16 | 7 | int:USP14 | |
| Interaction | EIF4A3 interactions | 5.16e-08 | 499 | 16 | 7 | int:EIF4A3 | |
| Interaction | SRSF6 interactions | 5.45e-08 | 503 | 16 | 7 | int:SRSF6 | |
| Interaction | BTF3 interactions | 5.72e-08 | 799 | 16 | 8 | int:BTF3 | |
| Interaction | SNRPB interactions | 6.57e-08 | 517 | 16 | 7 | int:SNRPB | |
| Interaction | TARDBP interactions | 6.84e-08 | 520 | 16 | 7 | int:TARDBP | |
| Interaction | MYPOP interactions | 8.82e-08 | 55 | 16 | 4 | int:MYPOP | |
| Interaction | CUL7 interactions | 8.82e-08 | 845 | 16 | 8 | int:CUL7 | |
| Interaction | SMURF1 interactions | 9.31e-08 | 544 | 16 | 7 | int:SMURF1 | |
| Interaction | ARIH2 interactions | 9.58e-08 | 314 | 16 | 6 | int:ARIH2 | |
| Interaction | GLDC interactions | 1.09e-07 | 321 | 16 | 6 | int:GLDC | |
| Interaction | METTL14 interactions | 1.11e-07 | 558 | 16 | 7 | int:METTL14 | |
| Interaction | RIOK1 interactions | 1.16e-07 | 562 | 16 | 7 | int:RIOK1 | |
| Interaction | CUL5 interactions | 1.23e-07 | 567 | 16 | 7 | int:CUL5 | |
| Interaction | PATZ1 interactions | 1.32e-07 | 163 | 16 | 5 | int:PATZ1 | |
| Interaction | ILF3 interactions | 1.39e-07 | 896 | 16 | 8 | int:ILF3 | |
| Interaction | UPF1 interactions | 1.46e-07 | 581 | 16 | 7 | int:UPF1 | |
| Interaction | HEXIM1 interactions | 1.60e-07 | 913 | 16 | 8 | int:HEXIM1 | |
| Interaction | HNRNPA0 interactions | 1.79e-07 | 349 | 16 | 6 | int:HNRNPA0 | |
| Interaction | PRMT1 interactions | 1.83e-07 | 929 | 16 | 8 | int:PRMT1 | |
| Interaction | MIR138-1 interactions | 2.09e-07 | 68 | 16 | 4 | int:MIR138-1 | |
| Interaction | OGT interactions | 2.17e-07 | 950 | 16 | 8 | int:OGT | |
| Interaction | MIR9-3 interactions | 2.35e-07 | 70 | 16 | 4 | int:MIR9-3 | |
| Interaction | SIRT6 interactions | 2.47e-07 | 628 | 16 | 7 | int:SIRT6 | |
| Interaction | MIR140 interactions | 2.49e-07 | 71 | 16 | 4 | int:MIR140 | |
| Interaction | MIR122 interactions | 2.49e-07 | 71 | 16 | 4 | int:MIR122 | |
| Interaction | MIR29B2 interactions | 2.49e-07 | 71 | 16 | 4 | int:MIR29B2 | |
| Interaction | PRC1 interactions | 2.61e-07 | 973 | 16 | 8 | int:PRC1 | |
| Interaction | MIR29B1 interactions | 2.79e-07 | 73 | 16 | 4 | int:MIR29B1 | |
| Interaction | MIR20A interactions | 2.95e-07 | 74 | 16 | 4 | int:MIR20A | |
| Interaction | MIR15A interactions | 3.11e-07 | 75 | 16 | 4 | int:MIR15A | |
| Interaction | U2AF2 interactions | 3.15e-07 | 651 | 16 | 7 | int:U2AF2 | |
| Interaction | SMC5 interactions | 3.22e-07 | 1000 | 16 | 8 | int:SMC5 | |
| Interaction | MIR7-3 interactions | 3.28e-07 | 76 | 16 | 4 | int:MIR7-3 | |
| Interaction | MIR16-1 interactions | 3.28e-07 | 76 | 16 | 4 | int:MIR16-1 | |
| Interaction | MIR199A2 interactions | 3.28e-07 | 76 | 16 | 4 | int:MIR199A2 | |
| Interaction | MIR429 interactions | 3.28e-07 | 76 | 16 | 4 | int:MIR429 | |
| Interaction | MIR9-2 interactions | 3.46e-07 | 77 | 16 | 4 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 3.46e-07 | 77 | 16 | 4 | int:MIR200A | |
| Interaction | EED interactions | 3.52e-07 | 1445 | 16 | 9 | int:EED | |
| Interaction | RLIM interactions | 3.54e-07 | 392 | 16 | 6 | int:RLIM | |
| Interaction | NEDD8 interactions | 3.59e-07 | 393 | 16 | 6 | int:NEDD8 | |
| Interaction | MIR92A1 interactions | 3.65e-07 | 78 | 16 | 4 | int:MIR92A1 | |
| Interaction | MIR98 interactions | 3.65e-07 | 78 | 16 | 4 | int:MIR98 | |
| Interaction | MIR451A interactions | 3.65e-07 | 78 | 16 | 4 | int:MIR451A | |
| Interaction | MIR222 interactions | 3.84e-07 | 79 | 16 | 4 | int:MIR222 | |
| Interaction | MIR206 interactions | 3.84e-07 | 79 | 16 | 4 | int:MIR206 | |
| Interaction | MIR1-2 interactions | 3.84e-07 | 79 | 16 | 4 | int:MIR1-2 | |
| Interaction | MIR34C interactions | 3.84e-07 | 79 | 16 | 4 | int:MIR34C | |
| Interaction | PCBP1 interactions | 3.87e-07 | 671 | 16 | 7 | int:PCBP1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 1.16e-02 | 473 | 16 | 2 | chr17q21 | |
| GeneFamily | RNA binding motif containing | 2.15e-11 | 213 | 12 | 7 | 725 | |
| GeneFamily | RNA binding motif containing|Serine and arginine rich splicing factors | 2.66e-05 | 12 | 12 | 2 | 737 | |
| GeneFamily | Keratins, type I | 1.51e-04 | 28 | 12 | 2 | 608 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 2.66e-06 | 166 | 16 | 4 | M8129 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN | 5.46e-06 | 199 | 16 | 4 | M8313 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | 8.87e-06 | 1394 | 16 | 7 | M9585 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | 9.08e-06 | 1399 | 16 | 7 | M535 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 1.68e-05 | 568 | 16 | 5 | M4023 | |
| Coexpression | AZARE_STAT3_TARGETS | 9.57e-05 | 24 | 16 | 2 | M2312 | |
| Coexpression | IBRAHIM_NRF1_UP | 1.02e-04 | 420 | 16 | 4 | M42509 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_DN | 1.08e-04 | 839 | 16 | 5 | M2099 | |
| Coexpression | GARY_CD5_TARGETS_DN | 1.21e-04 | 440 | 16 | 4 | M13893 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | 1.62e-04 | 474 | 16 | 4 | M40991 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 1.67e-04 | 180 | 16 | 3 | M8127 | |
| Coexpression | JISON_SICKLE_CELL_DISEASE_DN | 1.84e-04 | 186 | 16 | 3 | M4911 | |
| Coexpression | GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP | 1.99e-04 | 191 | 16 | 3 | M4916 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP | 2.28e-04 | 200 | 16 | 3 | M5787 | |
| Coexpression | GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP | 2.28e-04 | 200 | 16 | 3 | M5783 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP | 2.28e-04 | 200 | 16 | 3 | M5781 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP | 2.28e-04 | 200 | 16 | 3 | M5777 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP | 2.28e-04 | 200 | 16 | 3 | M7805 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.36e-04 | 523 | 16 | 4 | M12707 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 2.41e-04 | 204 | 16 | 3 | MM966 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | 2.55e-04 | 534 | 16 | 4 | MM1054 | |
| Coexpression | MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6 | 3.72e-04 | 47 | 16 | 2 | M1652 | |
| Coexpression | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP | 4.21e-04 | 50 | 16 | 2 | M6562 | |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | 4.58e-04 | 1144 | 16 | 5 | MM3843 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 4.91e-04 | 54 | 16 | 2 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 4.91e-04 | 54 | 16 | 2 | M2372 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C2 | 4.91e-04 | 54 | 16 | 2 | M2589 | |
| Coexpression | JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN | 6.68e-04 | 289 | 16 | 3 | M38973 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | 7.30e-04 | 705 | 16 | 4 | M1410 | |
| Coexpression | HAY_BONE_MARROW_PRO_B | 7.73e-04 | 304 | 16 | 3 | M39208 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 7.81e-04 | 305 | 16 | 3 | M40025 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 8.26e-04 | 311 | 16 | 3 | M40024 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 1.08e-03 | 341 | 16 | 3 | M2879 | |
| Coexpression | KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN | 1.09e-03 | 342 | 16 | 3 | M41062 | |
| Coexpression | SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP | 1.13e-03 | 82 | 16 | 2 | M9224 | |
| Coexpression | UEDA_CENTRAL_CLOCK | 1.36e-03 | 90 | 16 | 2 | M2637 | |
| Coexpression | UEDA_CENTRAL_CLOCK | 1.45e-03 | 93 | 16 | 2 | MM1141 | |
| Coexpression | FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL | 1.47e-03 | 380 | 16 | 3 | M41703 | |
| ToppCell | PBMC|World / Compartment, Disease Groups and Clusters | 6.35e-07 | 198 | 16 | 4 | 84f5b43dad0c57556171dbc0b799735654582ecf | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 136 | 16 | 3 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.47e-05 | 136 | 16 | 3 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.39e-05 | 180 | 16 | 3 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.62e-05 | 184 | 16 | 3 | cef3ee2a4a0af961aa3b4c92150d423e841ae8c1 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.86e-05 | 188 | 16 | 3 | 8bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.92e-05 | 189 | 16 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 196 | 16 | 3 | 66d76249bd2770cdddff2c1fe59a016e95da2124 | |
| ToppCell | 3'|World / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 196 | 16 | 3 | 44007f0c14e0f0703f7ee715b8eababb4d80a8b5 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 196 | 16 | 3 | 9bd4c146fc7555e32adfa393b3a07846eb826d25 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.37e-05 | 196 | 16 | 3 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-05 | 197 | 16 | 3 | 5bc11aff92da2a0aca8473f997fe7a99f3cae75d | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 198 | 16 | 3 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 198 | 16 | 3 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-05 | 198 | 16 | 3 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.57e-05 | 199 | 16 | 3 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 4.64e-05 | 200 | 16 | 3 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-1|ILC / Donor, Lineage, Cell class and subclass (all cells) | 7.84e-05 | 37 | 16 | 2 | 5208860d6b87c6c6fbf6e6c262fb2efc712ec2d3 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4-POLYDENDROCYTE_(Rostral-�migratory_stream-�(RMS)_(Stmn2))|Striatum / BrainAtlas - Mouse McCarroll V32 | 4.66e-04 | 90 | 16 | 2 | 7efc3437489c8587b9805547da1095f50d20cf6d | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.58e-04 | 107 | 16 | 2 | 60b272f5c89bea8a2714f870e18b7ac89a4a4bf6 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.58e-04 | 107 | 16 | 2 | c41bc8810df67158f0ae9f6015c965a8ebd96965 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4-POLYDENDROCYTE_(Neurogenesis.Sox4.Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.82e-04 | 124 | 16 | 2 | 1483be8700eca7e2c288784a290d945d4022b17f | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.34e-03 | 153 | 16 | 2 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.34e-03 | 153 | 16 | 2 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-03 | 162 | 16 | 2 | 7b2949eba2b4aea239d96ed82aafab13b07624eb | |
| ToppCell | facs-Lung-Endomucin-24m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-03 | 162 | 16 | 2 | 497ae9f86a5e7946d0fde932b35719a382a6b691 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 170 | 16 | 2 | ca88dc0b7a6960facb7c4d3c0f4795431a0a43d2 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 170 | 16 | 2 | b6882665a27c78a63f3b4a2a8806c8438a98e407 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 170 | 16 | 2 | 626c12b9a51218f72ee32afb5fd5d4b075025d75 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 1.64e-03 | 170 | 16 | 2 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | facs-Brain_Myeloid-Striatum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-03 | 170 | 16 | 2 | 31daac8696ae8c021c0302d3b30dd8194054b3e7 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-03 | 172 | 16 | 2 | 3f784aed340b50ddbec3f7dc0a5279180d38a2bb | |
| ToppCell | facs-Aorta-Heart-24m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.68e-03 | 172 | 16 | 2 | eae0f3e14e365dd8557a076d148dbe98352531b4 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(15)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.68e-03 | 172 | 16 | 2 | 7f3d0ef18f5df1ed80498d435b0378ca398c0b88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-03 | 174 | 16 | 2 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.76e-03 | 176 | 16 | 2 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.76e-03 | 176 | 16 | 2 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-03 | 177 | 16 | 2 | aadf1d10eccfb014cf3d621b1f01dd6d76df63ac | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.78e-03 | 177 | 16 | 2 | 9e65b39fd797b6ce204b6480415810d1923acee5 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.80e-03 | 178 | 16 | 2 | 89f0537459a321ded956bf70ad56fefc0854f8b0 | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 180 | 16 | 2 | 710526abedc8e0f9ba19ad69220df4c9468ada8f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.84e-03 | 180 | 16 | 2 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 181 | 16 | 2 | 0756d7d315b8cdd07a3cf6cdfc8a0679786b8e6a | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 181 | 16 | 2 | 3f0d88e9506d66d4e71b88c50d5187302065930f | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-24m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-03 | 181 | 16 | 2 | b09947d2d7b21f96d98b87ceb6f467ea329c4092 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.90e-03 | 183 | 16 | 2 | f20b0d71f857ac35868fd80531050ad8b6091716 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.92e-03 | 184 | 16 | 2 | 2df903924df9cb71039159416bcbe6a6614e21fe | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 184 | 16 | 2 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Skin|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.94e-03 | 185 | 16 | 2 | 657fd191ed160f8620d57b33820ec7222806f289 | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-03 | 186 | 16 | 2 | af038994a6c32261f426b0c40c39be4a9099fe43 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-03 | 186 | 16 | 2 | 2913b5fd0617d024d600ba7015ec7b1961dade83 | |
| ToppCell | 3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-03 | 186 | 16 | 2 | e265aac37f33947ff6c83f23f8a2c63bbccd60af | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.98e-03 | 187 | 16 | 2 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.98e-03 | 187 | 16 | 2 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD|kidney_cells / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-03 | 188 | 16 | 2 | 90188b60ff893754f7938fe8edab79758827168e | |
| ToppCell | facs-SCAT-Fat-3m|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 188 | 16 | 2 | b8dff61240e5052c2fbf7f28b86fe41822df45b0 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.01e-03 | 188 | 16 | 2 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 188 | 16 | 2 | ed35e438796cef302b6787c111753425922792dc | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.01e-03 | 188 | 16 | 2 | 2156f1bc849ff1cb09ae296d13bedd913ae6b43b | |
| ToppCell | droplet-Mammary_Gland|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-03 | 189 | 16 | 2 | d159892c9c4eb78d747ae6b44267a88cf870d31a | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 2.03e-03 | 189 | 16 | 2 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.03e-03 | 189 | 16 | 2 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.05e-03 | 190 | 16 | 2 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | facs-Large_Intestine-Distal-24m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-03 | 190 | 16 | 2 | a124e1c12af70161b9ead5d677afa660610444ee | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.05e-03 | 190 | 16 | 2 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.05e-03 | 190 | 16 | 2 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Occipital-15|World / Primary Cells by Cluster | 2.07e-03 | 191 | 16 | 2 | 190fadf6d7c5ba34d83ad6e5fa008451660db9cf | |
| ToppCell | Brain_organoid|World / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-03 | 191 | 16 | 2 | d93b280124b9888cd3f199d025bd6c7a1a709f2a | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.07e-03 | 191 | 16 | 2 | 6bc9c7c86040f3ebce08c350e625e345581d4550 | |
| ToppCell | facs-Tongue-nan-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-03 | 191 | 16 | 2 | 02f24202f9fdd46c648265a5b3b6f9066aa009fc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Occipital|World / Primary Cells by Cluster | 2.07e-03 | 191 | 16 | 2 | 467d6164aee7745d610cab512616dc7b69d2d8bd | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-lymphocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.09e-03 | 192 | 16 | 2 | ccdeb6f33246f5645ce8b04377adb2b369104c6c | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-new-cluster|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 192 | 16 | 2 | e4fb3f18da7dc6a835023db69a8d99737c39ef86 | |
| ToppCell | facs-Trachea-nan-18m-Epithelial-keratinocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.09e-03 | 192 | 16 | 2 | 4530b3028928d089b3a71eb19a4df237f58a50ae | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 193 | 16 | 2 | f074ebf9c5c53d8589d66b0109505f30baa1af81 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 193 | 16 | 2 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-03 | 193 | 16 | 2 | a7002acf3be76b2cc6fc9364176f6b0d3bd27d9c | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.11e-03 | 193 | 16 | 2 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 194 | 16 | 2 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | 10x3'2.3|World / cell types per 3 fetal stages;per 3',per 5' | 2.13e-03 | 194 | 16 | 2 | fc7ed8350ffe1475b8934dfbb107b51991876b0b | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 194 | 16 | 2 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte-new-cluster|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-03 | 194 | 16 | 2 | b847c5b4e8914b1c306bfff3d7119c32063784a8 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 194 | 16 | 2 | 592e8c4b73ba424a52305ac411ea9c0a2dc44467 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-keratinocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.13e-03 | 194 | 16 | 2 | bd94d30584128628b34ed8c3857ce103586cfe2e | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 195 | 16 | 2 | 2416efe0b10ef28d0107808d1347bc34f87f92b7 | |
| ToppCell | Control-B_naive-2|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.15e-03 | 195 | 16 | 2 | 50b1795eb37551777db13b8e9d2df1ef020bfa13 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 195 | 16 | 2 | 4d63e0dca30ae57960459d2fbcba09122273e37b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-03 | 195 | 16 | 2 | 661af601a3561fe3aacf2444ad7b8927fa88b48a | |
| ToppCell | 390C|World / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-03 | 195 | 16 | 2 | b955e83c2bf7a7e20ee50fab9dc9678f36d5bfd6 | |
| ToppCell | BAL-Control|BAL / Compartment, Disease Groups and Clusters | 2.15e-03 | 195 | 16 | 2 | bf940d836a34118a56bc956e6210e310510bca4d | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-lymphocytic-B_lymphocytic|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.18e-03 | 196 | 16 | 2 | 60cde394db9f1c39c258c3e7c01d3d1c76cc49a1 | |
| ToppCell | droplet-Thymus-nan-21m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-03 | 196 | 16 | 2 | 313d66313d7c93d9ae4c8b790262ba7a85b34fe4 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.18e-03 | 196 | 16 | 2 | 6ba02b806d440eed45bad7616bf3b8be57034427 | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 2.18e-03 | 196 | 16 | 2 | 7c3a99f0893c43d8c7980b560503844573d3b03c | |
| ToppCell | critical-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.18e-03 | 196 | 16 | 2 | dbf14f5851c2b779a8b35e820c4584ea9096e49d | |
| ToppCell | facs-Brain_Myeloid-Cortex_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 197 | 16 | 2 | 81379fe6bd14a1ba26f4a159497262adcb600b18 | |
| ToppCell | Basal-basal-6|World / Class top | 2.20e-03 | 197 | 16 | 2 | b4de7ffa078d90dda243ff511ec6c503ee5d8e94 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.20e-03 | 197 | 16 | 2 | 7290f05d0b8465637420119941bcbf2fae44a7e4 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 2.20e-03 | 197 | 16 | 2 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | facs-Brain_Myeloid-Cortex_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-03 | 197 | 16 | 2 | 271c75f491d03bd248c7ec037ef02e39456f3ac0 | |
| Computational | Neighborhood of DDX5 | 1.33e-08 | 65 | 14 | 5 | GCM_DDX5 | |
| Computational | RNA splicing. | 1.16e-06 | 65 | 14 | 4 | MODULE_183 | |
| Computational | Genes in the cancer module 98. | 5.38e-06 | 393 | 14 | 6 | MODULE_98 | |
| Computational | Genes in the cancer module 32. | 9.22e-06 | 241 | 14 | 5 | MODULE_32 | |
| Computational | Genes in the cancer module 198. | 2.80e-05 | 303 | 14 | 5 | MODULE_198 | |
| Computational | Genes in the cancer module 83. | 3.64e-05 | 320 | 14 | 5 | MODULE_83 | |
| Computational | Neighborhood of BECN1 | 3.05e-04 | 105 | 14 | 3 | MORF_BECN1 | |
| Computational | Neighborhood of HDAC1 | 3.50e-04 | 110 | 14 | 3 | GNF2_HDAC1 | |
| Computational | Neighborhood of APEX1 | 3.88e-04 | 114 | 14 | 3 | GCM_APEX1 | |
| Computational | Neighborhood of ACTG1 | 4.97e-04 | 124 | 14 | 3 | GCM_ACTG1 | |
| Computational | Neighborhood of CDC10 | 8.01e-04 | 146 | 14 | 3 | MORF_CDC10 | |
| Computational | Neighborhood of TDG | 9.15e-04 | 35 | 14 | 2 | GNF2_TDG | |
| Computational | Neighborhood of RAD21 | 1.02e-03 | 37 | 14 | 2 | GCM_RAD21 | |
| Computational | Neighborhood of PPP6C | 1.14e-03 | 39 | 14 | 2 | GNF2_PPP6C | |
| Computational | Neighborhood of ELAC2 | 1.58e-03 | 46 | 14 | 2 | GNF2_ELAC2 | |
| Computational | Neighborhood of JUND | 3.03e-03 | 64 | 14 | 2 | MORF_JUND | |
| Computational | TFs and nuclear. | 3.22e-03 | 237 | 14 | 3 | MODULE_252 | |
| Computational | Neighborhood of TERF1 | 3.32e-03 | 67 | 14 | 2 | MORF_TERF1 | |
| Computational | Neighborhood of BECN1 | 3.42e-03 | 68 | 14 | 2 | GCM_BECN1 | |
| Computational | Neighborhood of KPNB1 | 3.93e-03 | 73 | 14 | 2 | GNF2_KPNB1 | |
| Drug | AC1NRA5C | 1.46e-11 | 174 | 16 | 7 | CID005287709 | |
| Drug | AC1L1AUZ | 6.01e-08 | 157 | 16 | 5 | CID000001160 | |
| Drug | AC1L1B55 | 1.12e-05 | 454 | 16 | 5 | CID000001287 | |
| Drug | calcipotriene | 2.54e-05 | 11 | 16 | 2 | ctd:C055085 | |
| Drug | ((5Z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4H-imidazol-4-one) | 3.04e-05 | 12 | 16 | 2 | ctd:C578491 | |
| Drug | chlorophyllin | 3.91e-05 | 96 | 16 | 3 | ctd:C007020 | |
| Drug | VAI2 | 4.03e-05 | 97 | 16 | 3 | CID003474204 | |
| Drug | bromovanin | 9.00e-05 | 127 | 16 | 3 | ctd:C515564 | |
| Drug | potassium hydride | 9.21e-05 | 128 | 16 | 3 | CID000082127 | |
| Drug | betamethasone dipropionate | 9.65e-05 | 21 | 16 | 2 | CID000021800 | |
| Drug | Metribolone | 1.21e-04 | 382 | 16 | 4 | ctd:D015741 | |
| Drug | SK&F 83959 | 1.56e-04 | 153 | 16 | 3 | ctd:C080703 | |
| Drug | olomoucine II | 1.61e-04 | 27 | 16 | 2 | CID005494414 | |
| Drug | 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1.88e-04 | 163 | 16 | 3 | ctd:D015647 | |
| Drug | polycytidylic acid | 2.10e-04 | 169 | 16 | 3 | CID000000314 | |
| Drug | Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.87e-04 | 188 | 16 | 3 | 4835_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; MCF7; HT_HG-U133A | 2.87e-04 | 188 | 16 | 3 | 2805_DN | |
| Drug | Piracetam [7491-74-9]; Down 200; 28.2uM; MCF7; HT_HG-U133A | 3.00e-04 | 191 | 16 | 3 | 2861_DN | |
| Drug | sodium chromate(VI) | 3.04e-04 | 37 | 16 | 2 | ctd:C028982 | |
| Drug | Hyaluronic Acid | 3.14e-04 | 194 | 16 | 3 | ctd:D006820 | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; HL60; HG-U133A | 3.19e-04 | 195 | 16 | 3 | 1984_DN | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 3.29e-04 | 197 | 16 | 3 | 164_DN | |
| Drug | Zimelidine dihydrochloride monohydrate [61129-30-4]; Down 200; 9.8uM; PC3; HG-U133A | 3.29e-04 | 197 | 16 | 3 | 1930_DN | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.39e-04 | 199 | 16 | 3 | 4831_DN | |
| Drug | chromium nitrate | 4.11e-04 | 43 | 16 | 2 | ctd:C041167 | |
| Disease | Pachyonychia Congenita | 2.41e-06 | 5 | 15 | 2 | C0265334 | |
| Disease | colon adenocarcinoma (is_marker_for) | 7.19e-05 | 25 | 15 | 2 | DOID:234 (is_marker_for) | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 1.26e-04 | 33 | 15 | 2 | DOID:4467 (is_marker_for) | |
| Disease | Malignant neoplasm of skin | 4.06e-04 | 59 | 15 | 2 | C0007114 | |
| Disease | Skin Neoplasms | 4.06e-04 | 59 | 15 | 2 | C0037286 | |
| Disease | Mammary Neoplasms, Human | 2.17e-03 | 525 | 15 | 3 | C1257931 | |
| Disease | Mammary Carcinoma, Human | 2.17e-03 | 525 | 15 | 3 | C4704874 | |
| Disease | Mammary Neoplasms | 2.20e-03 | 527 | 15 | 3 | C1458155 | |
| Disease | Breast Carcinoma | 2.33e-03 | 538 | 15 | 3 | C0678222 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.65e-03 | 152 | 15 | 2 | DOID:0060041 (implicated_via_orthology) | |
| Disease | daytime rest measurement | 9.60e-03 | 295 | 15 | 2 | EFO_0007828 | |
| Disease | Malignant neoplasm of breast | 1.58e-02 | 1074 | 15 | 3 | C0006142 | |
| Disease | Intellectual Disability | 2.11e-02 | 447 | 15 | 2 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGTNRGYEGYGYGYG | 36 | Q9ULX6 | |
| RSYSRGGGDQGYGSG | 101 | P98179 | |
| GGGDQGYGSGRYYDS | 106 | P98179 | |
| GYGSGRYYDSRPGGY | 111 | P98179 | |
| RGSYGSSSFGGSYGG | 86 | P13645 | |
| ATRTYGGSYGGRGRG | 421 | P51116 | |
| YGSGFGSYGYGSGFG | 46 | Q8IUB9 | |
| MRRGAYGGGYGGYDD | 231 | P55795 | |
| YGYDDGYAVRGRGGG | 491 | O43390 | |
| MRRGAYGGGYGGYDD | 231 | P31943 | |
| SYSSCYSFGSGGGYG | 56 | Q04695 | |
| YGYRGRGRGYYQGGG | 71 | Q9NYF8 | |
| SGYRRGGSSYSGGGY | 1171 | Q08211 | |
| GGSSYSGGGYGGGYS | 1176 | Q08211 | |
| DGSYGSGRSGYGYRR | 76 | Q08170 | |
| GSGYDYSYAGGRGSY | 366 | P61978 | |
| YSYAGGRGSYGDLGG | 371 | P61978 | |
| SYGSRSGGGGYSSRR | 81 | Q13247 | |
| SYGGGGRYEEYRGYS | 301 | O75526 | |
| SGAGYGGYGAGSRAY | 1306 | Q9Y566 |